|
Systemic treatment of patients with inoperable and metastatic Merkel cell carcinoma: A multicenter study. |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Celon Pharma |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
|
|
Honoraria - Bristol-Myers Squibb; Novartis; Roche |
|
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Novartis |
|
Anna Malgorzata Czarnecka |
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche |
Research Funding - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche |
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Pierre Fabre; Roche |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Astellas Pharma; Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Merck |
|
|
Honoraria - Bristol-Myers Squibb; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Sanofi |
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Speakers' Bureau - Lilly; Novartis; Pfizer |
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre |